Cervical cancer

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

Who can joinWomen

Age18–75 years

Kind of studyObservational: no new treatment

What it testsWatches and records only

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Where to go

1 hospital in India taking patients for this trial.

Tata Memorial CenterMumbai, MaharashtraDirections ↗

Registry summary (technical)

Cervical cancer is the 4th most common cancer in women globally and the 2nd most common in India. In India, between 2018 and 2020, cervical cancer saw a surge of 26,985 from 2018 to 2020. The treatment for cervical cancer depends on the clinical stage. Treatment of early stage cervical cancer (Stage IB1-IIA) includes chemo-radiation or surgery +/- adjuvant (CT)RT and VBT if indicated. The choice of adjuvant treatment relies on identifying specific risk factors. Patients fulfilling Sedli's intermediate-risk criteria, requires pelvic radiotherapy alone and patients with high-risk Peter's criteri…

Sponsor: Tata Memorial Hospital
NCT07435623 on ClinicalTrials.gov
Last updated on the registry 2 Mar 2026 · read by us 20 Oct 2026

Cervical cancer

Where to go

Need help reaching the trial team? Write to us.